Previous close | 7.46 |
Open | 7.50 |
Bid | 7.04 x 400 |
Ask | 7.21 x 200 |
Day's range | 6.99 - 7.68 |
52-week range | 1.82 - 8.75 |
Volume | |
Avg. volume | 145,147 |
Market cap | 370.123M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Insights into Rani Therapeutics' First Quarter Results and Future Clinical Endeavors
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript March 20, 2024 Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.33. RANI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Kiki Patel: Operator: Welcome to […]